Medical Health & Life Science Research News

Research focused on the paclitaxel injection market forecast to 2022

Paclitaxel Injection Market is segmented geographically into North America, Europe, Asia Pacific and RoW. Currently the market is dominated by North America due to the high incidence of Cancer patients in this region. However, Europe and Asia Pacific are emerging markets due to rising incidences of cancer.

- Advertisement -
- Membership expired -

Paclitaxel injection is a gelatinous drug, which is obtained from Pacific yew trees, after chemical synthesis process. It’s a sub-segment of antineoplastic drug class, used to cure cancer in breast, lungs, ovaries, stomach, cervix and other.

Paclitaxel infection targets the tubulin, which is small globular protein in the human cell. It should be injected under the supervision of oncologist having experience in chemotherapy.

- Advertisement -
- Membership expired -
It is not prescribed by the physician if a patient has some allergic disease. Before prescribing this medication physician also confirm that patient is not suffering from high or low-pressure problem.

Paclitaxel injection has several side effect such as it cause allergy, decrease the WBC count and also generate blood pressure problems.

Download Sample Pages @ http://www.kminsights.com/request-sample-31078    

Paclitaxel Injection is used in the treatment of Breast cancer, Ovarian cancer, Non small cell lung cancer, AIDS related Kaposi's sarcoma, Cervical Cancer, Esophageal cancer, Prostate cancer , Stomach cancer, Testicular cancer, Lung cancer, Pancreatic cancer, and Others. According to the WHO, stomach cancer accounted for 723,000 deaths and breast cancer accounted for 521,000 deaths respectively in the year 2012 alone.

Paclitaxel is used for the treatment of both these cancers and the rising incidences of cancer would result in increased use of this drug for treatment.

The companies in this market are Abraxis Bio Science Inc., Celgene, Abbott Laboratories, Fresenius Kabi Oncology Ltd, Onco therapies Ltd, Novasep, Sagent Pharmaceuticals and others. The European Commission approved ABRAXANE to be taken in combination with Gentamicin for the treatment of metastatic pancreatic cancer in January 2014.

ABRAXANE was developed by Celgene International Sàrl, a subsidiary of Celgene Corporation.

Porter’s five force model analyzes the bargaining power of the suppliers and buyers as well as the threat of new entrants. The threat of substitutes in this market is high, with extensive research and development being carried out in anti-cancer drugs.

SWOT analysis helps in making strategic decisions for development and expansion. The key drivers, restraints and opportunities are analyzed to help in better understanding the growth of this market.

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Paclitaxel Injection in these regions, from 2017 to 2022 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
30 mg/5 mL
60 mg/10 mL
100 mg/16.7 mL
150 mg/25 mL
300 mg/50 mL
Split by application, this report focuses on consumption, market share and growth rate of Paclitaxel Injection in each application, can be divided into
Ovarian cancer
Breast cancer
Cervical cancer
Pancreatic cancer
Others

Download Sample Pages @ http://www.kminsights.com/request-sample-31078          

News From

Key Market InsightsKey Market Insights
Category: Market Research Publishers and RetailersCompany profile: Key Market Insights is a stand-alone organization with a solid history of advancing and exchanging market research reports and logical surveys delivered by our numerous transnational accomplices, which incorporate both huge multinationals and littler, more expert concerns. Our online stage, KMInsights.com, offers an unmatched gathering of market examination reports, organization audits, databooks, articles, periodical distributions, databases, on-line endorser administrations, and a great deal m ...

For more information:

Make an Inquiry about this report HERE!
  • www.kminsights.com/request-sample-31078
  • tinyurl.com/ybzbhu26